New painkiller may cut opioid use after major pancreatic surgery
NCT ID NCT07423650
First seen Feb 21, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tests whether a continuous infusion of nefopam, a non-opioid painkiller, can reduce the need for opioids and improve pain control after pancreatoduodenectomy (a major pancreatic surgery). About 93 adults scheduled for this surgery will be randomly assigned to receive nefopam, lidocaine, or epidural analgesia. Researchers will measure opioid use, pain scores, and recovery quality for 48 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prof. O. Fodor Regional Institute of Gastroenterology and Hepatology
RECRUITINGCluj-Napoca, Cluj, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.